335 related articles for article (PubMed ID: 12970111)
1. Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model.
Liao Y; Takashima S; Asano Y; Asakura M; Ogai A; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Ogita H; Tomoike H; Hori M; Kitakaze M
Circ Res; 2003 Oct; 93(8):759-66. PubMed ID: 12970111
[TBL] [Abstract][Full Text] [Related]
2. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
3. Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Asanuma H; Minamino T; Tomoike H; Hori M; Kitakaze M
Cardiovasc Res; 2005 Mar; 65(4):879-88. PubMed ID: 15721868
[TBL] [Abstract][Full Text] [Related]
4. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.
Jaffré F; Bonnin P; Callebert J; Debbabi H; Setola V; Doly S; Monassier L; Mettauer B; Blaxall BC; Launay JM; Maroteaux L
Circ Res; 2009 Jan; 104(1):113-23. PubMed ID: 19023134
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation.
Liao Y; Zhao H; Ogai A; Kato H; Asakura M; Kim J; Asanuma H; Minamino T; Takashima S; Kitakaze M
Hypertens Res; 2008 Feb; 31(2):335-44. PubMed ID: 18360054
[TBL] [Abstract][Full Text] [Related]
6. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
7. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K
J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A3 receptor deficiency exerts unanticipated protective effects on the pressure-overloaded left ventricle.
Lu Z; Fassett J; Xu X; Hu X; Zhu G; French J; Zhang P; Schnermann J; Bache RJ; Chen Y
Circulation; 2008 Oct; 118(17):1713-21. PubMed ID: 18838560
[TBL] [Abstract][Full Text] [Related]
9. Pressure overload causes cardiac hypertrophy in beta1-adrenergic and beta2-adrenergic receptor double knockout mice.
Palazzesi S; Musumeci M; Catalano L; Patrizio M; Stati T; Michienzi S; Di Certo MG; Mattei E; Vitelli L; Marano G
J Hypertens; 2006 Mar; 24(3):563-71. PubMed ID: 16467660
[TBL] [Abstract][Full Text] [Related]
10. Imperatorin prevents cardiac hypertrophy and the transition to heart failure via NO-dependent mechanisms in mice.
Zhang Y; Cao Y; Duan H; Wang H; He L
Fitoterapia; 2012 Jan; 83(1):60-6. PubMed ID: 21983344
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure.
Gallo P; Latronico MV; Gallo P; Grimaldi S; Borgia F; Todaro M; Jones P; Gallinari P; De Francesco R; Ciliberto G; Steinkühler C; Esposito G; Condorelli G
Cardiovasc Res; 2008 Dec; 80(3):416-24. PubMed ID: 18697792
[TBL] [Abstract][Full Text] [Related]
12. Activation of adenosine A1 receptor attenuates tumor necrosis factor-α induced hypertrophy of cardiomyocytes.
Liao Y; Lin L; Lu D; Fu Y; Bin J; Xu D; Kitakaze M
Biomed Pharmacother; 2011 Oct; 65(7):491-5. PubMed ID: 21993001
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A1 receptor expression during the transition from compensated pressure overload hypertrophy to heart failure.
Perlini S; Arosio B; Parmeggiani L; Santambrogio D; Palladini G; Tozzi R; Gatti C; Annoni G; Meyer TE; Ferrari AU
J Hypertens; 2007 Feb; 25(2):449-54. PubMed ID: 17211253
[TBL] [Abstract][Full Text] [Related]
14. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway.
Babiker FA; De Windt LJ; van Eickels M; Thijssen V; Bronsaer RJ; Grohé C; van Bilsen M; Doevendans PA
Circulation; 2004 Jan; 109(2):269-76. PubMed ID: 14718400
[TBL] [Abstract][Full Text] [Related]
15. G(alphaq)-protein carboxyl terminus imitation polypeptide GCIP-27 attenuates cardiac hypertrophy in vitro and in vivo.
Zhang HG; Li XH; Zhou JZ; Liu Y; Jia Y; Yuan ZB
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1276-81. PubMed ID: 17973867
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of brain Na sensitivity contributes to salt-induced sympathoexcitation and cardiac dysfunction in mice with pressure overload.
Ito K; Hirooka Y; Sunagawa K
Circ Res; 2009 Apr; 104(8):1004-11. PubMed ID: 19299647
[TBL] [Abstract][Full Text] [Related]
17. The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats.
Kassab S; Garadah T; Abu-Hijleh M; Golbahar J; Senok S; Wazir J; Gumaa K
J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):206-11. PubMed ID: 17318789
[TBL] [Abstract][Full Text] [Related]
18. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
Moreira VO; Pereira CA; Silva MO; Felisbino SL; Cicogna AC; Okoshi K; Aragon FF; Padovani CR; Okoshi MP; Castro AV
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):325-30. PubMed ID: 19278522
[TBL] [Abstract][Full Text] [Related]
20. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy.
Tzanidis A; Hannan RD; Thomas WG; Onan D; Autelitano DJ; See F; Kelly DJ; Gilbert RE; Krum H
Circ Res; 2003 Aug; 93(3):246-53. PubMed ID: 12842917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]